DE3784988D1 - Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686. - Google Patents

Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.

Info

Publication number
DE3784988D1
DE3784988D1 DE8787112861T DE3784988T DE3784988D1 DE 3784988 D1 DE3784988 D1 DE 3784988D1 DE 8787112861 T DE8787112861 T DE 8787112861T DE 3784988 T DE3784988 T DE 3784988T DE 3784988 D1 DE3784988 D1 DE 3784988D1
Authority
DE
Germany
Prior art keywords
main component
antibiotic complex
selective increase
organic main
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787112861T
Other languages
English (en)
Other versions
DE3784988T2 (de
Inventor
Giancarlo Lancini
Piero Antonini
Angelo Borghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE3784988D1 publication Critical patent/DE3784988D1/de
Application granted granted Critical
Publication of DE3784988T2 publication Critical patent/DE3784988T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dental Preparations (AREA)
DE8787112861T 1986-09-11 1987-09-03 Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686. Expired - Lifetime DE3784988T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868621911A GB8621911D0 (en) 1986-09-11 1986-09-11 Increasing ratio of components of anti-biotic complex

Publications (2)

Publication Number Publication Date
DE3784988D1 true DE3784988D1 (de) 1993-04-29
DE3784988T2 DE3784988T2 (de) 1993-07-08

Family

ID=10604035

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787112861T Expired - Lifetime DE3784988T2 (de) 1986-09-11 1987-09-03 Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.

Country Status (14)

Country Link
US (1) US5925550A (de)
EP (1) EP0259780B1 (de)
JP (1) JP2728406B2 (de)
KR (1) KR960013576B1 (de)
AT (1) ATE87335T1 (de)
CA (1) CA1301689C (de)
DE (1) DE3784988T2 (de)
DK (1) DK166628B1 (de)
ES (1) ES2038974T3 (de)
GB (1) GB8621911D0 (de)
HU (1) HU198229B (de)
IE (1) IE60223B1 (de)
IL (1) IL83736A (de)
ZA (1) ZA876773B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US20040062757A1 (en) * 2001-06-05 2004-04-01 Finegold Sydney M. Method of testing gastrointestinal diseases associated with species of genus clostridium
US20020013270A1 (en) * 2000-06-05 2002-01-31 Bolte Ellen R. Method for treating a mental disorder
CA2394616C (en) 2000-10-13 2007-05-15 Ecopia Biosciences Inc. Gene cluster for ramoplanin biosynthesis
US7144858B2 (en) * 2002-05-31 2006-12-05 The Trustees Of The University Of Pennsylvania Antibacterial compounds and methods for treating Gram positive bacterial infections
US7317001B2 (en) * 2002-06-06 2008-01-08 Oscient Pharmaceuticals Corporation Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
EP1565201B1 (de) * 2002-11-18 2018-10-31 Vicuron Pharmaceuticals, Inc. Methoden zur verabreichung von dalbavancin zur behandung bakterieller infektionen
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
CA2523573A1 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CN101024661B (zh) * 2006-02-24 2010-05-12 上海医药工业研究院 一种雷莫拉宁三种单组分的分离方法
US9707207B2 (en) 2010-05-26 2017-07-18 The United States Of America As Represented By The Department Of Veterans Affairs Method for diagnosing, preventing, and treating neurological diseases
US8883442B2 (en) 2011-07-13 2014-11-11 Foodchek Systems, Inc. Culture medium, method for culturing Listeria, and method for detecting Listeria
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163075D1 (en) * 1980-08-16 1984-05-17 Lepetit Spa Antibiotic a/16686 factor a2, the process for the preparation thereof, and the co-produced antibiotic a/16686 factors a1 and a3
JPH0612434B2 (ja) * 1985-05-17 1994-02-16 富士写真フイルム株式会社 ハロゲン化銀カラ−写真感光材料の処理方法
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
DE69019464T2 (de) * 1989-11-07 1995-09-28 Lepetit Spa Verfahren zur Rückgewinnung von Antibiotikum A/16686.

Also Published As

Publication number Publication date
JP2728406B2 (ja) 1998-03-18
ZA876773B (en) 1988-06-29
DK166628B1 (da) 1993-06-21
DK461787A (da) 1988-03-12
ATE87335T1 (de) 1993-04-15
IL83736A0 (en) 1988-02-29
ES2038974T3 (es) 1993-08-16
EP0259780B1 (de) 1993-03-24
CA1301689C (en) 1992-05-26
KR960013576B1 (ko) 1996-10-09
HU198229B (en) 1989-08-28
KR880004094A (ko) 1988-06-01
IE872421L (en) 1988-03-11
IE60223B1 (en) 1994-06-15
IL83736A (en) 1993-02-21
HUT46362A (en) 1988-10-28
DE3784988T2 (de) 1993-07-08
GB8621911D0 (en) 1986-10-15
JPS6377891A (ja) 1988-04-08
EP0259780A2 (de) 1988-03-16
EP0259780A3 (en) 1990-07-04
DK461787D0 (da) 1987-09-04
US5925550A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
DE3784988D1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE3882242D1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
DE3688336D1 (de) Verfahren zur herstellung von organischen saeuren unter verwendung von mikroorganismen.
DE3888393D1 (de) BICMOS-Verfahren zur Herstellung selbstausrichtender NPN-Emitter und -Basen sowie MOSFET-Sources und -Drains.
ATE41034T1 (de) Herstellung von protein a.
DE58904511D1 (de) Montageverfahren zur herstellung von led-zeilen.
DE3782590D1 (de) Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926.
DE3483664D1 (de) Verfahren zur herstellung von hochreinem kohlenmonoxid.
DE3861825D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan.
ATE95836T1 (de) Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung.
DE3876769D1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden.
DE3781878D1 (de) Antibiotikum-a10255-komplex und faktoren, verfahren, mikroorganismen fuer seine herstellung.
PT86619A (pt) Process for preparing alkylmelatonins
DE3869885D1 (de) Verfahren zur herstellung des gereinigten naphthalin-2,6-dicarbonsaeure-bis (2-hydroxyethyl)-esters.
DE69013425T2 (de) Pseudomonasmutant, yzh-Stamm und Verfahren zur Herstellung der 851yzh-Nährlösung mittels dieses Stammes.
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
ATE152176T1 (de) Verfahren zum regeln des norleucingehalts in polypeptiden
DE3882842D1 (de) Methode zur herstellung von cineolen.
DE3875885D1 (de) Methode zur herstellung von polycyclischen 1,3-thiazolidinen.
DE3850870T2 (de) Methode zur Herstellung von Beta substituiertem Allylsilane.
ATE91507T1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
ATE83506T1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy- 17-keto-steroiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOSEARCH ITALIA S.P.A., GERENZANO, IT

8327 Change in the person/name/address of the patent owner

Owner name: VICURON PHARMACEUTTICALS INC.(N.D.GES.STAATES DELA